Assessing the role of adolescent hormonal contraceptive use on risk for depression: a 3-year longitudinal study protocol.
Bita ZareianChristine AnderlJoelle LeMoultLiisa A M GaleaJerilynn C PriorJason D RightsColin J RossSabrina GeAnnie C HaywardFrances S ChenPublished in: BMC women's health (2022)
In this study we will assess the effect of CHC use during adolescence on development of Major Depressive Disorder (MDD). We will control for variables previously found to or proposed to partially account for the observed relationship between CHC use and MDD, including socioeconomic status, age of sexual debut, and CHC-related variables including age of first use, reasons for use, and its duration. In particular, we will discover whether CHC use increases depressive symptoms and/or MDD, whether elevated depressive symptoms and/or MDD predict a higher likelihood of starting CHC, or both. Furthermore, this study will allow us to clarify whether alterations in stress reactivity and social-emotional functioning serve as pathways through which CHC use may result in increased risk of depressive symptoms and/or MDD.